Tag: cancer

Russia is developing an mRNA cancer vaccine

An mRNA vaccine that works on all types of cancer has shown promising results in mice, Gamaleya Center director Alexander Gintsburg said in a June 6 interview with Gazeta.ru.

The drug is “being created based on mRNA technologies like the Pfizer and Moderna COVID-19 vaccines”, Gintsburg told the outlet, adding that his institute has its own mRNA platform that doesn’t rely on Western patents. The genetic vaccine will be custom-fit to each individual patient based on the results of tumor biopsies.

When asked about the vaccine’s safety, Gamaleya’s director said that the benefits of mRNA “therapeutic” vaccines outweigh the potential risks—but that the same cannot be said of “preventative” mRNA drugs.

Keep reading

Program to pay nuclear fallout victims expires due to U.S. House’s inaction

Faced with the choice of expanding or at minimum extending a program to offer compensation to victims of radioactive fallout from nuclear weapons testing during the Cold War, members of Congress did neither.

Despite repeated pleas from victims and their advocates, House Speaker Mike Johnson refused to allow House members to vote on a bipartisan bill that would expand and extend the Radiation Exposure Compensation Act (RECA). As a result, the program expired Friday, leaving victims of nuclear weapons detonations at the Nevada Test Site and their families to fend for themselves.

Several Downwinders — the name applied to tens of tens of thousands of people exposed to harmful radiation from nuclear testing at the Nevada site during the 1950s and early 1960s — expressed anger and a sense of betrayal that congressional leaders allowed the program to lapse.

St. George downwinder and longtime RECA advocate Claudia Peterson called the Congress’s failure to pass the legislation “a travesty.”

“This is something our government did to their own people,” said Peterson, who has lost her father, daughter, sister, neighbors and friends to various forms of cancer. “Our government is sending money all over the world and not even taking care of our own people that they damaged [due to nuclear testing] and are responsible for.”

Keep reading

‘Time to Ground the Plane’: FDA Advisers Recommend JN.1 COVID Vaccines Despite Growing Evidence of Cancer Risks

In a unanimous 16-0 vote, the U.S. Food and Drug Administration’s (FDA) vaccine advisory committee today recommended a monovalent JN.1-lineage vaccine composition for 2024-2025 Formula for COVID-19 vaccines.

The JN.1 variant has been most dominant this year, Reuters reported.

Last year, the agency’s committee recommended COVID-19 vaccines targeting XBB.1.5, a subvariant of Omicron that dominated the U.S. from November 2021 to 2022.

The committee today also discussed which specific strains within the JN.1-lineage group — such as subvariants KP.2 and KP.3 — the vaccines should target. The FDA said it will later issue an official recommendation to manufacturers about what subvariants it wants to target within the JN.1-lineage group.

David Wiseman, Ph.D., a bioscience researcher, told the committee that in recommending continued COVID-19 vaccination, the FDA may be putting the U.S. public’s health at risk. “Based on the totality of evidence, it is reasonable to believe that the product [COVID-19 vaccines] may be unsafe,” he said.

Keep reading

“I Was Offered Assisted Dying Over Cancer Treatment”: Broken Canadian Healthcare System Is Killing Patients

Two years ago, over the Thanksgiving holiday, Allison Ducluzeau started to feel pain in her stomach. At first, she assumed she had eaten too much turkey, but the pain persisted. A couple of weeks later, she saw her family doctor who requested CT scans, although none were sorted. Soon after, as the agony worsened, her partner insisted she went to the emergency unit at their local hospital on Vancouver Island. Finally, doctors confirmed the couple’s worst fears: she was almost certainly suffering from advanced abdominal cancer.

Allison, then 56, later learned that she had stage 4 peritoneal carcinomatosis, an aggressive condition. By the time she saw a specialist early last year, he warned that she might only live a few months longer: chemotherapy tended to be ineffective for her cancer, buying a bit more time at best, and she was inoperable. Instead, she was told to go home, sort out her papers, and decide if she wanted medical assistance in dying.

Unsurprisingly, Allison was devastated. “I could barely breathe — I went in there hoping to come out with a treatment plan but was just told to get my will in order.” That night was the worst of her life as she broke the shattering news to her son and daughter at her home in Victoria. “I told them I might only live for another two months,” she recalled. “If I’d not had my children, I might have accepted MAID [medical assistance in dying] — but when I saw the effect on them, having just been through the deaths of my own parents, it made me dig really deep.”

So, determined to find help, she researched her condition, spoke to doctors as far away as Taiwan, flew to California for scans and eventually travelled to Baltimore for treatment. She had discovered that patients could be given debulking surgery to reduce their cancer, followed by targeted use of heated chemotherapy — yet back in Canada, she could not get even an initial telephone chat with a surgeon who performed such operations for two months. Aided by her tight circle of friends and relatives, she raised almost half the $200,000 cost for the operation by crowdfunding. By the time she managed to see an oncologist in her home province of British Columbia, she was already on the road to recovery.

Today, Allison is in remission. She lifts weights daily, and goes running and cycling. She recently married her partner on a beach in Hawaii in front of her children. But she remains infuriated that Canadian doctors offered to kill rather than treat her. “The way it was presented was shocking,” she told me. “I was disgusted to be offered MAID twice. Once I was even on the phone, when I was on my own having just come back from Baltimore. It left me sobbing.”

As the debate over assisted dying heats up in Britain, with Keir Starmer promising a free vote on the matter if he wins the general election, and with politicians in Jersey approving plans for its use only last week, we should take notice of Allison’s case. For she does not share the ethical or religious concerns held by many opponents of euthanasia. Nor does she oppose Canada’s 2016 MAID reform; she agreed with her father five years later that it was an “appropriate” option for his intensifying pain after many years of prostate cancer.

But she has deep worries about assisted dying being offered by doctors in a health system that is floundering — especially with inadequate and overwhelmed oncology services when cancer patients comprise almost two-thirds of the soaring numbers of citizens opting for MAID. “We do not have a good standard of care here, especially for cancer — and that is why it is so dangerous to have MAID, especially when it can be used to take a bit of pressure off physicians and the government.” She knows of three other cancer patients whose families fear they died needlessly — including the person whose home she bought after downsizing to pay her medical bills in the US.

Allison’s very existence challenges those who argue that Britain — with its flailing health and social care systems, shamefully long waiting lists and historically poor cancer survival rates — should rush headlong into legalisation of assisted death. So, what would she tell those advocating for the reform? “I would tell Britain to only accept assisted dying when the health service is fixed — otherwise it is a very dangerous step to take. We deserve decent and timely care rather than offers of faster death.”

“I would tell Britain to only accept assisted dying when the health service is fixed.”

Keep reading

Two new studies suggest mRNA Covid vaccines can contribute to cancer formation

A new preprint provides evidence that the spike protein of both SARS-CoV-2 and mRNA vaccinations inhibits an important tumor suppressor protein, which may lead to increased incidence of cancer.

The preprint, titled ‘SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells,’ and published on 15 April, is authored by Brown University Professors Shengliang Zhang and Wafik El-Deiry. The latter is the Director of the Cancer Centre at the University.

The scientists set out to determine if the S2 component of the SARS-CoV-2 spike protein interacts with a tumor suppressor protein called p53. This particular protein is called the ‘guardian of the genome’ for its important role in DNA damage response and repair.

The authors found that S2 had a suppressive effect on p53, which suggests that “the SARS-CoV-2 spike causes an altered DNA damage sensing and repair response in cancer cells.”

In turn, this finding “provides a potential molecular mechanism by which SARS-CoV-2 infection may impact tumorigenesis, tumor progression and chemotherapy sensitivity.”

In other words, a component of the SARS-CoV-2 spike protein can lead to the development of tumors and may inhibit positive effects of cancer therapeutics.

Significantly, the authors note that this finding has implications for mRNA vaccines too, which instruct your body to make the very same spike protein as the wild SARS-CoV-2 spike protein. The authors write,

“Our results have implications for the biological effects of spike S2 subunit in human cells whether spike is present due to primary COVID-19 infection or due to mRNA vaccines where its expression is used to promote anti-viral immunity.”

Polymath Dr Jessica Rose has already offered a brief take in a post fittingly titled, ‘S2 of SARS-2 spike buggers up p53.’

Keep reading

Chemotherapy kills cancer patients faster than no treatment at all

Wishful thinking simply won’t deter from the fact that the cancer industry is just that: an industry. Doctors, drug companies, hospitals and other key stakeholders profit heavily each time a cancer patient submits to the conventional treatment model, which typically involves injecting chemotherapy poisons into the body, blasting it with ionizing radiation or cutting off body parts — or some barbaric combination of all three.

It might rub some people the wrong way to state this, especially those who’ve had to watch a loved one die from conventional cancer treatment, but each of these supposed treatments don’t actually work, in many cases. Little-known science, which the medical-industrial complex has made it a practice to ignore or cover up, reveals that, despite what the medical industry often claims, chemotherapy in particular just isn’t an effective cancer treatment.

Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, had been studying the lifespans of cancer patients for more than 25 years when he came to the conclusion that, despite popular belief, chemotherapy doesn’t work. He witnessed a multitude of cancer patients treated with the poison die horrific deaths, many of them meeting their fate much earlier than other patients who chose no treatment at all.

After investigating this further, Dr. Jones found that cancer patients who underwent chemotherapy actually died more quickly, in most cases, than those who followed their doctors’ recommendations by getting the treatment. A few number-crunching efforts later and Dr. Jones exposed a fact that the conventional cancer industry doesn’t want the world to know about its multi-billion-dollar cash cow.

“People who refused treatment lived for an average of 12 and a half years,” stated Dr. Jones about his study’s findings, which were published in the journal Transactions of the New York Academy of Sciences. “Those who accepted other kinds of treatment lived on an average of only 3 years.”

Keep reading

Insane & Gross Turbo Cancer Cases From Covid Shots Flooding Social Media

Extremely aggressive fast-acting turbo cancers are being widely discussed on social media site X (formally Twitter).

In a post on X from Tuesday ‘They Keep Saying Its Rare‘, a Covid vaccine adverse event reporting profile, documented a gruesome face cancer on a vaccine victim and linked the related study on the phenomenon.

The case report study detailed the serious Covid shot side effect which began just four days post vaccination.

“We report on an aggressive, infiltrating, metastatic, and ultimately lethal basaloid type of carcinoma arising shortly after an mRNA vaccination for COVID-19,” the study said in the ‘Abstract’ section. “We place this within the context of multiple immune impairments potentially related to the mRNA injections that would be expected to potentiate more aggressive presentation and progression of cancer.”

Keep reading

American oncologists take money from pharmaceutical companies for pure greed

Imagine if your car mechanic took $10,000 a year from Michelin tyres for “consulting” and then tended to recommend their tyres over Pirelli – even if the latter are on sale or better quality or both.

Imagine if your Governor took campaign contributions from Panera bread and then strangely exempted Panera bread from the new minimum wage law.

Imagine if your cancer doctor took money from Karyopharm and then prescribed the toxic poison selenexor (studied in the unethical trial Boston) over safer and cheaper alternatives.

To my knowledge, the first example didn’t happen. The second example is why people think Politicians are sleazy, and the last example is the norm in medicine.

Each year, cancer doctors – particularly academic doctors – take tens of millions in pharma payments while simultaneously writing guidelines that mandate the use of these drugs and simultaneously prescribing them to desperate sick patients who want an objective opinion, but get a biased one instead.

85% of National Comprehensive Cancer Network guidelines writers take pharma payments, and professional organisations are awash in Pharma cash. The American Society of Clinical Oncology (“ASCO”) – our annual meeting – is less about the objective appraisal of science and more a marketing conference for Pharma.

I don’t want to rehash the data showing taking money from Pharma is associated with greater, inappropriate, off-label prescribing, hype, spin and editorials favourable to the sponsor. There is a lot of literature there, and I have written about it extensively. Here, I want to address three things doctors who take personal payments say in rebuttal.

Keep reading

DNA Contamination in Pfizer COVID Shot 500 Times Permissible Level: New Study

Genetic impurities in the Pfizer mRNA COVID vaccine could be as high as 500 times the permissible limit, according to a new study.

In the study, published in Methods and Protocols, two German researchers raise worrying questions about the reliability of the quantitative PCR technique used by Pfizer-BioNTech to measure DNA contamination in the vaccine.

Using their own tests on the vaccine’s lipid nanoparticles, they discovered levels that were between 360 and 534 times higher than the 10 nanogram per dose limit set by regulators.

The researchers argued that the methods used by Pfizer-BioNTech test for only 1% of the original DNA template used to make the vaccine, meaning that 99% of the genetical material from the template therefore goes untested and potentially undetected.

Similar concerns have been raised by other researchers.

Keep reading

Pfizer agrees to settle 10,000 lawsuits accusing pharma giant of hiding cancer risks of heartburn drug Zantac

Pfizer has agreed to settle more than 10,000 lawsuits alleging it it of hiding the cancer risks of its heartburn drug Zantac.

The financial details have not been revealed but pharma rival Sanofi agreed to pay more than $100million to resolve 4,000 Zantac-cancer claims last nonth.

The over-the-counter pill was pulled in the US in 2020 after animal studies found a key ingredient released ‘probable human carcinogens’.

Pfizer was the primary manufacturer of Zantac from 1998 to 2006, when several suits claim it should have known that the drug was contaminated with NDMA.

Plaintiffs claimed the drug was contaminated with the impurity through improper manufacturing practices, and that Pfizer withheld this information from consumers.

NDMA is a chemical byproduct of many industrial manufacturing processes, including the production of rocket fuel.

Keep reading